Howard Chu, Yeon Woo Jung, Su Min Kim, Byung Gi Bae, Jung Min Bae, Lark Kyun Kim, Kwang Hoon Lee, Chang Ook Park
{"title":"探索相互作用:肥胖、脂代谢和特应性皮炎的临床表现。","authors":"Howard Chu, Yeon Woo Jung, Su Min Kim, Byung Gi Bae, Jung Min Bae, Lark Kyun Kim, Kwang Hoon Lee, Chang Ook Park","doi":"10.5021/ad.23.151","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The interest toward the association between atopic dermatitis (AD) and obesity is increasing, yet the possibility of abnormal lipid metabolism has never been investigated before.</p><p><strong>Objective: </strong>To identify the characteristics of patients with AD who are obese and analyze the serum lipid profiles of these patients.</p><p><strong>Methods: </strong>This observational study included 167 patients diagnosed with AD and underwent evaluations for serum lipid panels between July 2017 and October 2017. The patients' body mass index was used to determine obesity and the serum lipid panels were analyzed between patients who are obese and non-obese. Also, the disease severity and subjective symptoms were evaluated and serum total immunoglobulin E (IgE) and specific IgE levels were assessed.</p><p><strong>Results: </strong>Of the 167 patients with AD, there were 36 obese and 131 non-obese subjects. Obese patients were found to have a significantly higher disease severity, as well as higher serum triglyceride and low-density lipoprotein-cholesterol levels and lower high-density lipoprotein-cholesterol levels, which was most pronounced in adult males. Obesity AD patients also had a significantly higher serum total IgE, itch intensity score, and number of allergens sensitized.</p><p><strong>Conclusion: </strong>Patients with AD who are obese should be monitored for possible abnormalities in lipid metabolism. Obesity may be a factor that contributes to a higher disease severity of AD.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"36 5","pages":"310-317"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439982/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the Interplay: Obesity, Lipid Metabolism, and Clinical Manifestations in Atopic Dermatitis.\",\"authors\":\"Howard Chu, Yeon Woo Jung, Su Min Kim, Byung Gi Bae, Jung Min Bae, Lark Kyun Kim, Kwang Hoon Lee, Chang Ook Park\",\"doi\":\"10.5021/ad.23.151\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The interest toward the association between atopic dermatitis (AD) and obesity is increasing, yet the possibility of abnormal lipid metabolism has never been investigated before.</p><p><strong>Objective: </strong>To identify the characteristics of patients with AD who are obese and analyze the serum lipid profiles of these patients.</p><p><strong>Methods: </strong>This observational study included 167 patients diagnosed with AD and underwent evaluations for serum lipid panels between July 2017 and October 2017. The patients' body mass index was used to determine obesity and the serum lipid panels were analyzed between patients who are obese and non-obese. Also, the disease severity and subjective symptoms were evaluated and serum total immunoglobulin E (IgE) and specific IgE levels were assessed.</p><p><strong>Results: </strong>Of the 167 patients with AD, there were 36 obese and 131 non-obese subjects. Obese patients were found to have a significantly higher disease severity, as well as higher serum triglyceride and low-density lipoprotein-cholesterol levels and lower high-density lipoprotein-cholesterol levels, which was most pronounced in adult males. Obesity AD patients also had a significantly higher serum total IgE, itch intensity score, and number of allergens sensitized.</p><p><strong>Conclusion: </strong>Patients with AD who are obese should be monitored for possible abnormalities in lipid metabolism. Obesity may be a factor that contributes to a higher disease severity of AD.</p>\",\"PeriodicalId\":94298,\"journal\":{\"name\":\"Annals of dermatology\",\"volume\":\"36 5\",\"pages\":\"310-317\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439982/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5021/ad.23.151\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5021/ad.23.151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:人们对特应性皮炎(AD)与肥胖之间的关系越来越感兴趣,但对脂质代谢异常的可能性却从未进行过研究:确定肥胖 AD 患者的特征,并分析这些患者的血清脂质谱:这项观察性研究纳入了167名确诊为AD的患者,他们在2017年7月至2017年10月期间接受了血清脂质谱的评估。患者的体重指数用于确定肥胖程度,并对肥胖和非肥胖患者的血清脂质谱进行分析。此外,还对疾病严重程度和主观症状进行了评估,并对血清总免疫球蛋白E(IgE)和特异性IgE水平进行了评估:结果:在 167 名 AD 患者中,有 36 名肥胖者和 131 名非肥胖者。结果发现,肥胖患者的疾病严重程度明显更高,血清甘油三酯和低密度脂蛋白胆固醇水平更高,而高密度脂蛋白胆固醇水平更低,这在成年男性中最为明显。肥胖AD患者的血清总IgE、瘙痒强度评分和过敏原数量也明显更高:结论:应监测肥胖的AD患者是否可能出现脂质代谢异常。肥胖可能是导致 AD 疾病严重程度较高的一个因素。
Exploring the Interplay: Obesity, Lipid Metabolism, and Clinical Manifestations in Atopic Dermatitis.
Background: The interest toward the association between atopic dermatitis (AD) and obesity is increasing, yet the possibility of abnormal lipid metabolism has never been investigated before.
Objective: To identify the characteristics of patients with AD who are obese and analyze the serum lipid profiles of these patients.
Methods: This observational study included 167 patients diagnosed with AD and underwent evaluations for serum lipid panels between July 2017 and October 2017. The patients' body mass index was used to determine obesity and the serum lipid panels were analyzed between patients who are obese and non-obese. Also, the disease severity and subjective symptoms were evaluated and serum total immunoglobulin E (IgE) and specific IgE levels were assessed.
Results: Of the 167 patients with AD, there were 36 obese and 131 non-obese subjects. Obese patients were found to have a significantly higher disease severity, as well as higher serum triglyceride and low-density lipoprotein-cholesterol levels and lower high-density lipoprotein-cholesterol levels, which was most pronounced in adult males. Obesity AD patients also had a significantly higher serum total IgE, itch intensity score, and number of allergens sensitized.
Conclusion: Patients with AD who are obese should be monitored for possible abnormalities in lipid metabolism. Obesity may be a factor that contributes to a higher disease severity of AD.